Medical News

RSS

Insight into global incidence and prevalence of mild cognitive impairment

New research reported today in Paris at the Alzheimer's Association International Conference 2011 (AAIC 2011) offers insight on the global incidence and prevalence of mild cognitive impairment (MCI) – a condition involving problems with memory or another mental function severe enough to be noticeable to the affected person or to others but not serious enough to interfere with daily life.

19 Jul 2011

Study finds high C-section rates in Florida, New Jersey and Texas

A report released today by HealthGrades, the nation's most trusted, independent source of physician information and hospital quality outcomes, found that between 2002 and 2009 the C-section, or Cesarean section, rate in the U.S. rose from 27% of all single births to 34%, an all-time high. The highest rates of C-section were found in Florida, New Jersey and Texas, the lowest in Utah, Wisconsin and Colorado.

19 Jul 2011

First neurobiological evidence for theory of episodic memory

Almost everyone has experienced one memory triggering another, but explanations for that phenomenon have proved elusive. Now, University of Pennsylvania researchers have provided the first neurobiological evidence that memories formed in the same context become linked, the foundation of the theory of episodic memory.

19 Jul 2011

Food4Me project to investigate potential of personalised nutrition

When the human genome sequence was launched in 2000, it introduced the possibility of personalisation in health care. Such personalisation can be applied to nutrition, a key health determinant, to create a diet tailored specifically for an individual, according to their individual physical and genetic make-up. Food4Me is a new, EU (FP7) funded project investigating the potential of this personalised nutrition.

19 Jul 2011

Scientists discover cholesterol moves far slower within and between cells

Neutrons have shown the movement of cholesterol between and within cells takes far longer than previously thought. Findings could impact the treatment of a range of diseases linked to abnormal rates of cholesterol transfer.

19 Jul 2011

Thalidomide analog shows promise against sickle cell disease

A thalidomide analog is shaping up as a safe, worthy opponent of sickle cell disease, Georgia Health Sciences University researchers report.

19 Jul 2011

Columbia University receives NIH grant to expand clinical, translational research

A Columbia University institute, whose goal is to accelerate the pace of translating science into real-life treatments for patients, received $38.9 million from the National Institutes of Health to expand its work over the next five years.

19 Jul 2011

Teens with positive sense of well-being more likely to report being healthy in young adulthood

A new study finds that teens with a positive sense of well-being are more likely to report being healthy in young adulthood. The research suggests this is not just because teenagers who feel good about themselves are healthy in the first place.

19 Jul 2011

A*Star Institute of Microelectronics shortens drug development cycle with new silicon-based screening tool

Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.

19 Jul 2011

Biomax Informatics expands long-term licensing and services agreement with DSM

Biomax Informatics today announced the expansion of its long-term licensing and services agreement with Royal DSM to include solutions for synthetic biology using Biomax's BioXM Knowledge Management Environment.

19 Jul 2011

Scientists identify new inherited form of Parkinson's disease

Scientists at the Helmholtz Zentrum München and the Technische Universität München working in cooperation with the Medical University of Vienna have identified a mutation associated with a inherited form of late-onset Parkinson's disease.

19 Jul 2011

Simple lifestyle changes could prevent half of all Alzheimer's disease cases

Over half of all Alzheimer's disease cases could potentially be prevented through lifestyle changes and treatment or prevention of chronic medical conditions, according to a study led by Deborah Barnes, PhD, a mental health researcher at the San Francisco VA Medical Center.

19 Jul 2011

Cegedim, Hitachi partner to offer Customer Relationship Management solutions

Hitachi, Ltd. and Cegedim Relationship Management today announced a formal strategic partnership to offer Customer Relationship Management (CRM) solutions to Life Sciences companies in the Asia Pacific region.

19 Jul 2011

Researchers identify potential therapeutic target for ER-negative breast cancer

Using a new in vivo screening system, Whitehead Institute researchers have identified a protein in the serine biosynthesis pathway that is essential in estrogen receptor (ER)-negative breast cancer—a notoriously difficult disease to treat associated with low five-year survival rates.

19 Jul 2011

Aeterna's AEZS-108 final Phase 2 results in endometrial cancer to be presented at ESGO 2011

Aeterna Zentaris Inc. today announced that final Phase 2 results in endometrial cancer on its anticancer compound, AEZS-108, will be presented during a poster session at the upcoming 17th International Meeting of the European Society of Gynaecological Oncology, to be held September 11-14, 2011, at the Milan Convention Center in Milan, Italy.

19 Jul 2011

UCSF receives NIH grant to translate science into real-life solutions

A UCSF institute aimed at accelerating the pace of translating science into real-life solutions for patients has received $112 million from the National Institutes of Health to expand its work over the next five years.

19 Jul 2011

Convergence initiates CNV1014802 Phase II study in lumbosacral radiculopathy

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the Phase II proof of concept study with CNV1014802 for treating pain associated with lumbosacral radiculopathy (LSR) has started.

19 Jul 2011

Scientists find way to make copper-catalyzed click chemistry biocompatible

Biomolecular imaging can reveal a great deal of information about the inner workings of cells and one of the most attractive targets for imaging are glycans - sugars that are ubiquitous to living organisms and abundant on cell surfaces. Imaging a glycan requires that it be tagged or labeled. One of the best techniques for doing this is a technique called click chemistry.

19 Jul 2011

Mayo Clinic licenses M. tuberculosis complex speciation test from QIAGEN

Mayo Clinic has licensed patent rights from QIAGEN to enable Mayo Medical Laboratories to offer an M. tuberculosis complex speciation test. The test expands Mayo Medical Laboratories' current offering for tuberculosis testing, which already includes M. tuberculosis complex culture, molecular identification and drug susceptibility testing.

From QIAGEN Manchester Limited 19 Jul 2011

Catylix, Illinois enter license agreement to incorporate fluorine into drugs

Catylix, Inc. and the University of Illinois at Urbana-Champaign have entered into a license agreement under which Catylix will utilize a technology developed by Illinois' Professor John Hartwig to quickly and efficiently introduce fluorine and fluorine-containing substituents into molecules.

19 Jul 2011